 China Money Network.jpg)
Insights
20-Feb-18 Fosun International and London-based healthcare and life science company Arix Bioscience have agreed to jointly develop innovative clinical therapies across a broad range of therapeutic areas for patients, with a focus on the Chinese markets. [image: China Money Network]
Read More
 Small Caps.jpg)
Insights
13-Feb-18 Australia's Eagle Health, which produces a range of traditional Chinese medicine and Western nutritional products, has launched its clinically-tested ‘Hutang 1’ product to combat Type 2 diabetes and blood glucose imbalances in Chinese pharmacies, supermarkets and online. [image: Small Caps]
Read More
 Business Korea.jpg)
Insights
16-Jan-18 The US had the most clinical trials in the world in 2017, with 24% of all trials, and Korea ranked sixth with a 3.5% market share. Seoul topped the list of the most clinical trials per city. [image: Business Korea]
Read More
 Reuters.jpg)
Insights
28-Dec-18 TVM Capital Healthcare Partners, a Dubai-based private equity business, has launched a USD250 mn fund to invest in areas ranging from cancer to pharmaceuticals in markets including the Gulf, Turkey, Egypt, India and Singapore. [image: Reuters]
Read More
 Business Korea.jpg)
Insights
08-Dec-17 Chinese investors plan to solidify their position in Korea by investing in the country's future industries such as biotech companies, being sought out by the likes of KKR, a global private equity firm, and affiliates of China’s CITIC Securities. [image: Business Korea]
Read More
